If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
Myelodysplastic Syndromes Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Erythropoietin Medicine & Life Sciences
Anemia Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Granulocyte Colony-Stimulating Factor Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Thrombocytopenia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2019

  • 2287 Citations
  • 25 h-Index
  • 96 Article
  • 1 Chapter
  • 1 Letter

Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study

Messa, E., Gioia, D., Masiera, E., Castiglione, A., Ceccarelli, M., Salvi, F., Danise, P., Sanna, A., Allione, B., Balleari, E., Poloni, A., Cametti, G., Ferrero, D., Tassara, R., Finelli, C., Bonferroni, M., Musto, P., Saglio, G., Levis, A. & Santini, V., 2019, In : Haematologica. 104, 1, p. e4-e8

Research output: Contribution to journalArticle

Effects of erythropoiesis-stimulating agents on overall survival of IPSS low/INT-1 risk, transfusion independent myelodysplastic syndrome patients: a cohort study

Messa, E., Gioia, D., Masiera, E., Castiglione, A., Ceccarelli, M., Salvi, F., Danise, P., Sanna, A., Allione, B., Balleari, E., Poloni, A., Cametti, G., Ferrero, D., Tassara, R., Finelli, C., Bonferroni, M., Musto, P., Saglio, G., Levis, A. & Santini, V., Aug 3 2018, In : Haematologica.

Research output: Contribution to journalArticle

Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS)

Fabiani, E., Calabrese, C., Niscola, P., Balleari, E., Molteni, A., Finelli, C., Falconi, G., Fenu, S., Fianchi, L., Criscuolo, M., Salvi, F., Lavorgna, S., Buccisano, F., Maurillo, L., Lo Coco, F., Cilloni, D. & Voso, M. T., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

29 Citations (Scopus)

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Oliva, E. N., Alati, C., Santini, V., Poloni, A., Molteni, A., Niscola, P., Salvi, F., Sanpaolo, G., Balleari, E., Germing, U., Fenaux, P., Stamatoullas, A., Palumbo, G. A., Salutari, P., Impera, S., Avanzini, P., Cortelezzi, A., Liberati, A. M., Carluccio, P., Buccisano, F. & 12 othersVoso, M. T., Mancini, S., Kulasekararaj, A., Morabito, F., Bocchia, M., Cufari, P., Spiriti, M. A. A., Santacaterina, I., D'Errigo, M. G., Bova, I., Zini, G. & Latagliata, R., Mar 1 2017, In : The Lancet Haematology. 4, 3, p. e127-e136

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Thrombocytopenia
Placebos
Blood Platelets
Hemorrhage
29 Citations (Scopus)

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Oliva, E. N., Alati, C., Santini, V., Poloni, A., Molteni, A., Niscola, P., Salvi, F., Sanpaolo, G., Balleari, E., Germing, U., Fenaux, P., Stamatoullas, A., Palumbo, G. A., Salutari, P., Impera, S., Avanzini, P., Cortelezzi, A., Liberati, A. M., Carluccio, P., Buccisano, F. & 12 othersVoso, M. T., Mancini, S., Kulasekararaj, A., Morabito, F., Bocchia, M., Cufari, P., Spiriti, M. A. A., Santacaterina, I., D'Errigo, M. G., Bova, I., Zini, G. & Latagliata, R., Mar 2017, In : The Lancet Haematology. 4, 3, p. e127-e136

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Thrombocytopenia
Placebos
Blood Platelets
Hemorrhage